155 related articles for article (PubMed ID: 10857164)
1. Molecular diagnosis of head and neck cancer.
van Houten VM; van den Brekel MW; Denkers F; Colnot DR; Westerga J; van Diest PJ; Snow GB; Brakenhoff RH
Recent Results Cancer Res; 2000; 157():90-106. PubMed ID: 10857164
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
3. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
4. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
[TBL] [Abstract][Full Text] [Related]
5. Genetic diagnosis of micrometastasis based on SCC antigen mRNA in cervical lymph nodes of head and neck cancer.
Hamakawa H; Fukizumi M; Bao Y; Sumida T; Onishi A; Tanioka H; Sato H; Yumoto E
Clin Exp Metastasis; 1999; 17(7):593-9. PubMed ID: 10845558
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma.
Shores CG; Yin X; Funkhouser W; Yarbrough W
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):937-42. PubMed ID: 15313863
[TBL] [Abstract][Full Text] [Related]
7. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
BMC Med; 2015 May; 13():108. PubMed ID: 25956054
[TBL] [Abstract][Full Text] [Related]
9. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
10. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction.
Nieuwenhuis EJ; Leemans CR; Kummer JA; Denkers F; Snow GB; Brakenhoff RH
Lab Invest; 2003 Aug; 83(8):1233-40. PubMed ID: 12920252
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
van Dongen GA; Brakenhoff RM; ten Brink CT; van Gog FB; de Bree R; Quak JJ; Snow GB
Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843
[TBL] [Abstract][Full Text] [Related]
12. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
[TBL] [Abstract][Full Text] [Related]
13. New molecular diagnostic methods in head and neck cancer.
Rodrigo JP; Ferlito A; Suárez C; Shaha AR; Silver CE; Devaney KO; Bradley PJ; Bocker JM; McLaren KM; Grénman R; Rinaldo A
Head Neck; 2005 Nov; 27(11):995-1003. PubMed ID: 16200629
[TBL] [Abstract][Full Text] [Related]
14. Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin.
Califano J; Westra WH; Koch W; Meininger G; Reed A; Yip L; Boyle JO; Lonardo F; Sidransky D
J Natl Cancer Inst; 1999 Apr; 91(7):599-604. PubMed ID: 10203278
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
16. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
17. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.
Brakenhoff RH; Stroomer JG; ten Brink C; de Bree R; Weima SM; Snow GB; van Dongen GA
Clin Cancer Res; 1999 Apr; 5(4):725-32. PubMed ID: 10213205
[TBL] [Abstract][Full Text] [Related]
18. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.
Partridge M; Li SR; Pateromichelakis S; Francis R; Phillips E; Huang XH; Tesfa-Selase F; Langdon JD
Clin Cancer Res; 2000 Jul; 6(7):2718-25. PubMed ID: 10914716
[TBL] [Abstract][Full Text] [Related]
19. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
[TBL] [Abstract][Full Text] [Related]
20. Molecular assay to detect metastatic head and neck squamous cell carcinoma.
Becker MT; Shores CG; Yu KK; Yarbrough WG
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):21-7. PubMed ID: 14732763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
